AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

NASDAQ:PDSBPDS Biotechnology Earnings Date, Estimates & History

$1.29
+0.07 (+5.74 %)
(As of 06/2/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.25
Now: $1.29
$1.32
50-Day Range
$0.72
MA: $0.98
$1.31
52-Week Range
$0.62
Now: $1.29
$7.19
Volume470,082 shs
Average Volume482,258 shs
Market Capitalization$19.82 million
P/E RatioN/A
Dividend YieldN/A
Beta2.83

Earnings

PDS Biotechnology (NASDAQ:PDSB) Earnings Information

PDS Biotechnology last issued its quarterly earnings data on March 27th, 2020. The reported ($0.52) EPS for the quarter. PDS Biotechnology has generated ($3.57) earnings per share over the last year. PDS Biotechnology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 6th, 2020 based off prior year's report dates.

PDS Biotechnology Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PDS Biotechnology (NASDAQ:PDSB) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.14 EPS
Next Year EPS Consensus Estimate: $-0.85 EPS

PDS Biotechnology (NASDAQ PDSB) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/6/2020
(Estimated)
       
5/13/20203/31/2020($0.15)($0.39)($0.39)Transcript
3/27/2020Q4 2019($0.52)($0.20)N/A
11/7/2019Q3($0.82)($1.10)($1.10)N/A
8/1/2019Q2 2019($0.75)($0.75)N/A
5/14/2019Q1 2019($1.07)($3.61)N/A
2/21/2019Q4 2018($0.40)$1.20N/A
11/1/2018Q3 2018($2.20)($1.60)N/A
8/1/2018Q2 2018($4.00)$0.20N/A
5/1/2018Q1 2018($11.60)($9.80)N/A
3/1/2018Q4 2017($9.40)($9.00)($9.00)N/A
11/1/2017Q3 2017($9.60)($7.40)($7.40)N/A
8/1/2017Q2 2017($9.00)($8.80)($8.80)N/A
5/3/2017Q1 2017($8.40)($8.40)($8.40)N/A
3/2/2017Q4 2016($8.20)($6.60)($6.60)N/A
11/1/2016Q3 2016($7.60)($7.40)($7.40)N/A
8/3/2016Q2 2016($6.80)($6.60)($6.60)N/A
5/3/2016Q1 2016($8.40)($6.40)($6.40)N/A
3/8/2016Q4 2015($5.60)($6.00)($6.00)N/A
11/6/2015Q3 2015($4.60)($141.60)($141.60)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.